U.S. Patent Disclosures
Tuesday, January 18, 2011
Immunitor USA Inc., of College Park, Md., has received U.S. Patent No. 7,838,006, titled "Viral vaccine composition, process and methods of use," relating to claims covering the composition of matter for Immunitor's lead product, V5.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.